Sequence and structural determinants of efficacious de novo chimaeric antigen receptors.
PubMed / NCBI E-utilities · 學術索引收錄 · 來源發佈：Wed Sep 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 09:08:08 GMT+0000 (Coordinated Universal Time)
已保存的原文節選
Advances in generative protein design using artificial intelligence (AI) have enabled the rapid development of binders against heterogeneous targets, including tumour-associated antigens. Despite extensive biochemical characterization, these novel protein binders have had limited evaluation in candidate therapeutics, including chimaeric antigen receptor (CAR) T cells. Here we synthesize generative
以上為帶出處的原文節選，完整內容請閱讀原始鏈接。自動收錄與主題分類不等於事實核驗。